Similarly, a backpack loaded with an IL-15 super-agonist increased T cell-mediated tumor clearance by mouse CD8+ T cells and human chimeric antigen receptor (CAR)-T cell therapy in a mouse model (Tang et al., 2018). Here, CD8A is linked to neoplasm.